wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26778318-C1269711-DE4A-4A6D-92E4-395DA90FF9DB
Q26778318-C1269711-DE4A-4A6D-92E4-395DA90FF9DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26778318-C1269711-DE4A-4A6D-92E4-395DA90FF9DB
Dacomitinib in lung cancer: a "lost generation" EGFR tyrosine-kinase inhibitor from a bygone era?
P2860
Q26778318-C1269711-DE4A-4A6D-92E4-395DA90FF9DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26778318-C1269711-DE4A-4A6D-92E4-395DA90FF9DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1f0cc2633d7005a22335a2f30f5b19ff425ddf59
P2860
U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations.